Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

ClinicalTrials.gov ID: NCT06516965

Public ClinicalTrials.gov record NCT06516965. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 4:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis.

Study identification

NCT ID
NCT06516965
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Incyte Corporation
Industry
Enrollment
346 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 10, 2024 (Actual)
Primary completion
Oct 19, 2026 (Estimated)
Completion
May 3, 2027 (Estimated)
Last update posted
Apr 14, 2026

2024 – 2027

United States locations

U.S. sites
28
U.S. states
16
U.S. cities
27
Facility City State ZIP Site status
Medical Dermatology Specialists Phoenix Phoenix Arizona 85006 —
Investigate Md Scottsdale Arizona 85255 —
First Oc Dermatology Research Inc Fountain Valley California 92708-3701 —
Clinical Science Institute Clinical Research Specialists Inc Santa Monica California 90404 —
Center For Clinical and Cosmetic Research Aventura Florida 33180 —
Schweiger Dermatology Boca Raton Florida 33428 —
Direct Helpers Research Center Hialeah Florida 33012 —
Skin Care Research, Llc Hollywood Florida 33201 —
Ziaderm Research, Llc Miami Florida 33162 —
Nodal Medical Center, Llc Tampa Florida 33607 —
Trueblue Clinical Research Moore Clinical Research, Inc McR Tampa Clinic Location Tampa Florida 33609 —
Dermatology Specialists Research Louisville Kentucky 40241 —
University of Maryland School of Medicine Baltimore Maryland 21201 —
Dermatology Associates Pc Rockville Maryland 20850 —
Metro Boston Clinical Partners Brighton Massachusetts 02135-3511 —
Fivenson Dermatology Ann Arbor Michigan 48103 —
Henry Ford Health System Detroit Michigan 48202 —
Michigan Dermatology Institute Waterford Michigan 48328 —
Allcutis Research, Llc Portsmouth New Hampshire 03801 —
Schweiger Dermatology Hackensack New Jersey 07601 —
OPTISKIN New York New York 10128 —
University of Cincinnati Cancer Institute Cincinnati Ohio 45267 —
Central Sooner Research Oklahoma City Oklahoma 73118 —
Paddington Testing Co Inc Philadelphia Pennsylvania 19103 —
Yardley Dermatology Associates Yardley Pennsylvania 19067 —
Modern Research Associates Pllc Dallas Texas 75231 —
University of Utah Midvalley Dermatology Murray Utah 84107 —
Aesthetic General Dermatology of Seattle Burien Washington 98168 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 91 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06516965, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 14, 2026 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06516965 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →